Publications
Below you will find an archive of all of the Pathways Study manuscripts that have been thus far published. We have also made available for each publication a hyperlink to their abstract on PubMed. You can search our publications table by key word or sort by column.
 Authors | Title | Journal | Month2 | Year1 | Volume / Pages | PMCID |
|---|---|---|---|---|---|---|
| Yao S; Chua AV, Jr.; Greenlee H; Kwan ML; Kushi LH | Authors' Reply to the Letter to the Editor by Batalini et al: Observational Data on Vitamin D Do Not Justify Routine Screening or Supplementation to Improve Breast Cancer Outcomes | J Natl Compr Canc Netw | Aug | 2026 | 24 | |
| Bitsie KR; Pearson TA; Kwan ML; Yaghjyan L; Scarton L; Shariff-Marco S; Andraos TY; D'Addario LL; Kushi LH; Cheng TD | Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study | Breast Cancer Res Treat | Aug | 2026 | 218 | PMC13457354 |
| Sampathkumar Y; Zakaria Z; O'Connell K; Bhimani J; Blinder VS; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer | JCO Oncol Pract | Dec | 2025 | PMC12700344 | |
| Jayasekera JC; Wilson OWA; Schechter C; Jin JLC; Wojcik KM; van Ravesteyn NT; Wall J; Schneider J; D'Addario LL; Roh JM; Sarkar S; Cadmus-Bertram L; Pierce JP; Trentham-Dietz A; Kushi LH; Matthews CE | Development and Validation of a Simulation Model-Based Tool to Support Individualized Physical Activity Discussions and Prescriptions for Breast Cancer Survivors | JCO Clin Cancer Inform | Oct | 2025 | 9:e2500151 | PMC12543000 |
| Bhimani J; Wang P; Gallagher GB; O'Connell K; Persaud S; Blinder VS; Burganowski R; Ergas IJ; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Roh JM; Tabatabai S; Valice E; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer | Breast Cancer Res Treat | Aug | 2025 | 213:115–126 | PMC12289320 |
| Bhimani J; O'Connell K; Gallagher GB; Blinder VS; Burganowski R; Ergas IJ; Griggs JJ; Heon N; Jinna S; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Wang P; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer | NPJ Breast Cancer | Oct | 2025 | 11:119 | PMC12572154 |
| Yao S; Zimbalist A; Sheng H; Fiorica P; Cheng RK; Mendicino L; Omilian AR; Zhu Q; Roh JM; Laurent CA; Lee VS; Ergas IJ; Iribarren C; Rana JS; Nguyen-Huynh M; Rillamas-Sun E; Hershman DL; Ambrosone CB; Kushi LH; Greenlee H; Kwan ML | Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast Cancer | medRxiv | Apr | 2026 | PMC13131716 | |
| Yao S; Chua AV, Jr.; Sheng H; Zimbalist A; Hill JW; Roh JM; D'Addario LL; Laurent CA; Ergas IJ; Cheng TD; Johnson CS; Ambrosone CB; Greenlee H; Kwan ML; Kushi LH | Clinically Sufficient Vitamin D Levels With Survival and Cardiovascular Outcomes in a Prospective Cohort of 3,995 Individuals Diagnosed With Invasive Breast Cancer | J Natl Compr Canc Netw | Mar | 2026 | 24 | |
| Wang P; O'Connell K; Bhimani J; Blinder V; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Sampathkumar Y; Monroy-Iglesias MJ; Bandera EV; Kushi LH; Kantor ED; Aiello Bowles EJ | Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings | Int J Cancer | Mar | 2026 | 158:1481–1488 | PMC13007531 |
| Shariff-Marco S; Von Behren J; Chirikova E; Inamdar PP; Wadhwa M; Allen L; D'Addario L; Roh JM; Ambrosone CB; Kushi LH; Reynolds P; Gomez SL | Assessing Upstream Structural and Social Drivers of Health in Breast Cancer Survivorship: The Pathways Study Neighborhood Resource | Cancer Epidemiol Biomarkers Prev | Feb | 2026 | 35:198–209 | PMC12959897 |
| Sampathkumar Y; Zakaria Z; O'Connell K; Bhimani J; Blinder VS; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Monroy-Iglesias MJ; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Wang P; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Response to Yu, Wang, and Ge | J Natl Cancer Inst | Jul | 2026 | 118:1332–1333 | PMC13321121 |
| Sampathkumar Y; Zakaria Z; O'Connell K; Bhimani J; Blinder VS; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Monroy-Iglesias MJ; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Wang P; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer | J Natl Cancer Inst | Jul | 2026 | 118:1278–1289 | PMC13033348 |
| Monroy-Iglesias MJ; O'Connell K; Bhimani J; Blinder VS; Burganowski-Doud RP; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Sampathkumar Y; Tabatabai S; Valice E; Wang P; Aiello Bowles EJ; Bandera EV; Kushi LH; Kantor ED | Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer | Cancer | Mar | 2026 | 132:e70294 | PMC13179111 |
| Kwan ML; D'Addario L; Lee C; Roh JM; Ergas IJ; Shariff-Marco S; Cheng I; Von Behren J; Wu AH; Morey BN; Castillo E; Kim MO; Lin K; Loo LWM; Kurian A; Omilian AR; John EM; Yao S; Gomez SL; Kushi LH | Differences in breast cancer survival across Asian American ethnicities compared with non-Latina White females in Kaiser Permanente Northern California | J Natl Cancer Inst | Jul | 2026 | 118:1266–1277 | PMC13339151 |
| Jayasekera J; Ergas IJ; Schneider J; Tian E; Wojcik KM; Roh JM; Vo JB; Kushi LH; Wilson OWA; McGee EE | Tailored Exercise Strategies and Mortality Among Breast Cancer Survivors | JAMA Netw Open | Apr | 2026 | 9:e265177 | PMC13077521 |
| Gomez SL; Von Behren J; McGuire V; Kim MO; Gao L; Shariff-Marco S; Lin K; Cheng I; Kwan ML; Wu AH; John EM; Loo L; Kurian A; Koo J; D'Addario L; Roh JM; Ergas IJ; Castillo E; Ambrosone CB; Morey BN; Kushi LH; Yao S | Breast Cancer Survival in Asian American Patients | JAMA Netw Open | Jul | 2026 | 9:e2621041 | PMC13324866 |
| Fiorica PN; Zimbalist A; Sheng H; Laurent CA; Roh JM; Lee VS; Ergas IJ; Delmerico J; Zhu Q; Cheng RK; Rillamas-Sun E; Iribarren C; Rana JS; Nguyen-Huynh M; Hershman DL; Ambrosone CB; Kushi LH; Greenlee H; Kwan ML; Yao S | Polygenic Risk for Cardiometabolic and Cardiovascular Disease in a Multiethnic Cohort of Breast Cancer Survivors | JACC CardioOncol | Feb | 2026 | 8:65–76 | PMC12922620 |
| Fiorica PN; Kushi LH; Greenlee H; Kwan ML; Yao S | Reply: Polygenic Risk Scores for Cardiovascular Disease in Breast Cancer Survivors: Implications for Asian Populations | JACC CardioOncol | Jun | 2026 | ||
| Diaz AE; Kwan ML; Laurent CA; Rillamas-Sun E; Roh JM; Iribarren C; Rana JS; Kushi LH; Reding KW; Quesenberry CP; Greenlee H; Cheng RK | Disparities in cardiometabolic and cardiovascular risk after breast cancer: the Pathways Heart Study | JNCI Cancer Spectr | Jan | 2026 | 10 | PMC12888380 |
| Bhimani J; O'Connell K; Blinder VS; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Jinna S; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Valice E; Bandera EV; Bowles EJA; Kushi LH; Kantor ED | The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer | Cancer | Mar | 2026 | 132:e70318 | PMC13326849 |
| Aiello Bowles EJ; O'Connell K; Bhimani J; Gallagher GB; Blinder VS; Doud RB; Ergas IJ; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Wang P; Bandera EV; Kushi LH; Kantor ED | Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer | J Natl Cancer Inst | Feb | 2026 | 118:307–315 | PMC12928258 |
| Gulbahce HE; Bernard PS; Weltzien EK; Factor RE; Kushi LH; Caan BJ; Sweeney C | Differences in molecular features of triple-negative breast cancers based on the age at diagnosis | Cancer | Dec | 2018 | 124:4676–4684 | PMC6294689 |
| Nierenberg JL; Adamson AW; Hu D; Huntsman S; Patrick C; Li M; Steele L; Tao S; Ding YC; Tong B; Shieh Y; Fejerman L; Gruber SB; Haiman CA; John EM; Kushi LH; Torres-Mejia G; Ricker C; Weitzel JN; Ziv E; Neuhausen SL | Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women | Nat Commun | Aug | 2025 | 16:7816 | PMC12370925 |
| Nierenberg JL; Adamson AW; Hu D; Huntsman S; Patrick C; Li M; Steele L; Tong B; Shieh Y; Fejerman L; Gruber SB; Haiman CA; John EM; Kushi LH; Torres-Mejia G; Ricker C; Weitzel JN; Ziv E; Neuhausen SL | Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer | medRxiv | Jan | 2023 | PMC9901069 | |
| Morey BN; Garcia S; Lin K; Canchola AJ; Alexeeff SE; Kurtovich EM; Uong S; Aoki RF; Guan A; Torres JM; Shariff-Marco S; Yao S; Kushi LH; Gomez SL; Kroenke CH | A validation study for measuring Asian- and Hispanic-serving sociocultural institutions in neighborhoods using business listing data and potential implications for health | Soc Sci Med | Sep | 2024 | 356:117143 | PMC11330724 |
| Kwan ML; Haque R; Lee VS; Joanie Chung WL; Avila CC; Clancy HA; Quinn VP; Kushi LH | Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries | Cancer Causes Control | Sep | 2012 | 23:1587–91 | PMC3418812 |
| Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP | Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease | J Oncol Pract | Jul | 2019 | 15:e616–e627 | PMC6804885 |
| Liu Q; Hu Q; Yao S; Kwan ML; Roh JM; Zhao H; Ambrosone CB; Kushi LH; Liu S; Zhu Q | SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data | Genomics Proteomics Bioinformatics | Apr | 2019 | 17:211–218 | PMC6620264 |
| Greenlee H; Rillamas-Sun E; Cheng R; Iribarren C; Rana JS; Nguyen-Huynh M; Kushi LH; Kwan ML | Reply to M.S. Ewer et al | J Clin Oncol | Dec | 2022 | 40:4159–4160 | PMC9746758 |
| Madsen MJ; Knight S; Sweeney C; Factor R; Salama M; Stijleman IJ; Rajamanickam V; Welm BE; Arunachalam S; Jones B; Rachamadugu R; Rowe K; Cessna MH; Thomas A; Kushi LH; Caan BJ; Bernard PS; Camp NJ | Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15 | Cancer Epidemiol Biomarkers Prev | Jun | 2018 | 27:644–652 | PMC5984724 |
| Bhimani J; O'Connell K; Persaud S; Blinder V; Burganowski-Doud RP; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Rivera DR; Roh JM; Tabatabai S; Valice E; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer | Cancer Epidemiol Biomarkers Prev | Oct | 2024 | 33:1286–1297 | PMC11844798 |
| Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED | Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer | JCO Clin Cancer Inform | Apr | 2024 | 8:e2300209 | PMC11902409 |
| Palmer JR; Boggs DA; Wise LA; Ambrosone CB; Adams-Campbell LL; Rosenberg L | Parity and lactation in relation to estrogen receptor negative breast cancer in African American women | Cancer Epidemiol Biomarkers Prev | Sep | 2011 | 20:1883–91 | PMC3179178 |
| Lieu TA; Ray GT; Prausnitz SR; Habel LA; Alexeeff S; Li Y; Ramsey SD; Phelps CE; Chawla N; S CON; Mandelblatt JS | Oncologist and organizational factors associated with variation in breast cancer multigene testing | Breast Cancer Res Treat | May | 2017 | 163:167–176 | PMC5394102 |
| Leoce NM; Jin Z; Kehm RD; Roh JM; Laurent CA; Kushi LH; Terry MB | Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer | Breast Cancer Res | Sep | 2021 | 23:91 | PMC8474887 |
| Christensen BC; Marsit CJ; Houseman EA; Godleski JJ; Longacker JL; Zheng S; Yeh RF; Wrensch MR; Wiemels JL; Karagas MR; Bueno R; Sugarbaker DJ; Nelson HH; Wiencke JK; Kelsey KT | Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles | Cancer Res | Aug | 2009 | 69:6315–21 | PMC2755616 |
| Ritzwoller DP; Fishman PA; Banegas MP; Carroll NM; O'Keeffe-Rosetti M; Cronin AM; Uno H; Hornbrook MC; Hassett MJ | Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis | Health Serv Res | Dec | 2018 | 53:5106–5128 | PMC6232408 |
| Bhimani J; O'Connell K; Persaud S; Blinder V; Burganowski RP; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Rivera DR; Roh JM; Tabatabai S; Valice E; Bandera EV; Aiello Bowles EJ; Kushi LH; Kantor ED | The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system | Breast Cancer Res Treat | Nov | 2024 | 208:405–414 | PMC12045552 |
| Uong SP; Torres JM; Alexeeff SE; Morey BN; Caan BJ; Kushi LH; Kroenke CH | Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education among Women Diagnosed with Breast Cancer | Cancer Epidemiol Biomarkers Prev | May | 2024 | 33:694–702 | PMC11062809 |
| Ray GT; Mandelblatt J; Habel LA; Ramsey S; Kushi LH; Li Y; Lieu TA | Breast cancer multigene testing trends and impact on chemotherapy use | Am J Manag Care | May | 2016 | 22:e153–60 | PMC4940166 |
| Chandler Y; Schechter CB; Jayasekera J; Near A; O'Neill SC; Isaacs C; Phelps CE; Ray GT; Lieu TA; Ramsey S; Mandelblatt JS | Cost Effectiveness of Gene Expression Profile Testing in Community Practice | J Clin Oncol | Feb | 2018 | 36:554–562 | PMC5815401 |
| Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP, Jr.; Habel LA; Caan BJ | Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression | BMC Cancer | Apr | 2015 | 15:278 | PMC4403771 |
| Kantor ED; O'Connell K; Ergas IJ; Valice E; Roh JM; Bhimani J; Heon N; Griggs JJ; Lee J; Bowles EJ; Rivera DR; Kolevska T; Bandera EV; Kushi LH | Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system | Breast Cancer Res Treat | Feb | 2024 | 203:565–574 | PMC10885738 |
| Wang P; O'Connell K; Bhimani J; Blinder V; Burganowski R; Ergas IJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bandera EV; Kushi LH; Aiello Bowles EJ; Kantor ED | Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study | JCO Clin Cancer Inform | Feb | 2025 | 9:e2400231 | PMC11839177 |
| Kroenke CH; Aoki R; Kushi LH; Torres JM; Morey BN; Gomez S; Caan B; Canchola AJ; Alexeeff S | Associations Between Immigrant Status and Dietary Patterns in ENCLAVE, A Pooled, Observational Study of Women Diagnosed With Breast Cancer | J Nutr | Jun | 2025 | PMC12323724 | |
| Banegas MP; Hassett MJ; Keast EM; Carroll NM; O'Keeffe-Rosetti M; Fishman PA; Uno H; Hornbrook MC; Ritzwoller DP | Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer | Value Health | Jan | 2022 | 25:69–76 | |
| Huang Y; Kwan ML; Heckbert SR; Smith NL; Othus M; Laurent CA; Roh JM; Rillamas-Sun E; Lee VS; Kolevska T; Cheng RK; Irribarren C; Nguyen-Huynh M; Hershman DL; Kushi LH; Greenlee H | Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors | J Natl Cancer Inst | Jul | 2025 | 117:1401–1409 | |
| Bhimani J; Wang P; Gallagher GB; O'Connell K; Blinder V; Burganowski R; Ergas IJ; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Roh JM; Tabatabai S; Valice E; Bandera EV; Bowles EJA; Kushi LH; Kantor ED | Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer | Int J Cancer | Oct | 2025 | 157:1342–1353 | PMC12335361 |
| Bhimani J; O'Connell K; Persaud S; Blinder V; Burganowski R; Ergas IJ; Foley MJ; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Rivera DR; Roh JM; Tabatabai S; Valice E; Bandera EV; Bowles EJA; Kushi LH; Kantor ED | Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer | Int J Cancer | Nov | 2024 | 155:1577–1592 | PMC11781235 |
| Aoki RL; Alexeeff SE; Caan BJ; Kushi LH; Gomez SL; Torres JM; Canchola AJ; Morey BN; Kroenke CH | Nativity and Healthy Lifestyle Index in a Pooled Cohort of Female Breast Cancer Survivors from Northern California | Cancer Epidemiol Biomarkers Prev | Jul | 2025 | 34:1188–1198 | PMC12213179 |
| Liang E; Beshara M; Sheng H; Huang XW; Roh JM; Laurent CA; Lee C; Delmerico J; Tang L; Lo JC; Hong CC; Ambrosone CB; Kushi LH; Kwan ML; Yao S | A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer | Breast Cancer Res Treat | Nov | 2024 | 208:349–358 | Not available |
| Kushi LH; Kwan ML; Lee MM; Ambrosone CB | Lifestyle factors and survival in women with breast cancer | J Nutr | Jan | 2007 | 137:236S–242S | Not available |
| Kwan ML; Ambrosone CB; Lee MM; Barlow J; Krathwohl SE; Ergas IJ; Ashley CH; Bittner JR; Darbinian J; Stronach K; Caan BJ; Davis W; Kutner SE; Quesenberry CP; Somkin CP; Sternfeld B; Wiencke JK; Zheng S; Kushi LH | The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California | Cancer Causes Control | Dec | 2008 | 19:1065–76 | PMC2581640 |
| Greenlee H; Kwan ML; Ergas IJ; Sherman KJ; Krathwohl SE; Bonnell C; Lee MM; Kushi LH | Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study | Breast Cancer Res Treat | Oct | 2009 | 117:653–65 | PMC2991094 |
| Kwan ML; Kushi LH; Weltzien E; Maring B; Kutner SE; Fulton RS; Lee MM; Ambrosone CB; Caan BJ | Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors | Breast Cancer Res | 2009 | 11:R31 | PMC2716499 | |
| Christensen BC; Kelsey KT; Zheng S; Houseman EA; Marsit CJ; Wrensch MR; Wiemels JL; Nelson HH; Karagas MR; Kushi LH; Kwan ML; Wiencke JK | Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake | PLoS Genet | Jul | 2010 | 6:e1001043 | PMC2912395 |
| Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI | Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients | J Clin Oncol | Sep | 2010 | 28:4120–8 | PMC2953970 |
| Kwan ML; Darbinian J; Schmitz KH; Citron R; Partee P; Kutner SE; Kushi LH | Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study | Arch Surg | Nov | 2010 | 145:1055–63 | PMC2997775 |
| Kwan ML; Ergas IJ; Somkin CP; Quesenberry CP, Jr.; Neugut AI; Hershman DL; Mandelblatt J; Pelayo MP; Timperi AW; Miles SQ; Kushi LH | Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study | Breast Cancer Res Treat | Sep | 2010 | 123:507–24 | PMC2935682 |
| Kwan ML; Kushi LH; Song J; Timperi AW; Boynton AM; Johnson KM; Standley J; Kristal AR | A practical method for collecting food record data in a prospective cohort study of breast cancer survivors | Am J Epidemiol | Dec | 2010 | 172:1315–23 | PMC3025629 |
| Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI | Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer | Breast Cancer Res Treat | Apr | 2011 | 126:529–37 | PMC3462663 |
| Mandelblatt JS; Luta G; Kwan ML; Makgoeng SB; Ergas IJ; Roh JM; Sternfeld B; Adams-Campbell LL; Kushi LH | Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study | Breast Cancer Res Treat | Sep | 2011 | 129:521–9 | PMC3152655 |
| Kwan ML; Sternfeld B; Ergas IJ; Timperi AW; Roh JM; Hong CC; Quesenberry CP; Kushi LH | Change in physical activity during active treatment in a prospective study of breast cancer survivors | Breast Cancer Res Treat | Jan | 2012 | 131:679–90 | PMC3273453 |
| Livaudais JC; Hershman DL; Habel L; Kushi L; Gomez SL; Li CI; Neugut AI; Fehrenbacher L; Thompson B; Coronado GD | Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer | Breast Cancer Res Treat | Jan | 2012 | 131:607–17 | PMC3375495 |
| Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL | Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL) | Breast Cancer Res Treat | Jul | 2012 | 134:419–28 | PMC3561459 |
| Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL | Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study | J Clin Oncol | Nov | 2012 | 30:3800–9 | PMC3478575 |
| Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL | The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy | Breast J | May | 2012 | 18:203–13 | PMC3519420 |
| Hillyer GC; Hershman DL; Kushi LH; Lamerato L; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Rana S; Neugut AI | A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions | Breast | Aug | 2013 | 22:548–54 | PMC3640652 |
| Kroenke CH; Kwan ML; Neugut AI; Ergas IJ; Wright JD; Caan BJ; Hershman D; Kushi LH | Social networks, social support mechanisms, and quality of life after breast cancer diagnosis | Breast Cancer Res Treat | Jun | 2013 | 139:515–27 | PMC3906043 |
| Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL | Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007 | Breast Cancer Res Treat | Jan | 2013 | 137:247–60 | PMC3769522 |
| Kwan ML; Tam EK; Ergas IJ; Rehkopf DH; Roh JM; Lee MM; Somkin CP; Stewart AL; Kushi LH | Patient-physician interaction and quality of life in recently diagnosed breast cancer patients | Breast Cancer Res Treat | Jun | 2013 | 139:581–95 | PMC3707405 |
| Shelton RC; Clarke Hillyer G; Hershman DL; Leoce N; Bovbjerg DH; Mandelblatt JS; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Neugut AI | Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study | Breast Cancer Res Treat | Feb | 2013 | 137:817–28 | PMC3563273 |
| Timperi AW; Ergas IJ; Rehkopf DH; Roh JM; Kwan ML; Kushi LH | Employment status and quality of life in recently diagnosed breast cancer survivors | Psychooncology | Jun | 2013 | 22:1411–20 | PMC3519968 |
| Vin-Raviv N; Hillyer GC; Hershman DL; Galea S; Leoce N; Bovbjerg DH; Kushi LH; Kroenke C; Lamerato L; Ambrosone CB; Valdimorsdottir H; Jandorf L; Mandelblatt JS; Tsai WY; Neugut AI | Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study | J Natl Cancer Inst | Apr | 2013 | 105:563–72 | PMC3627645 |
| Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP, Jr.; Castillo A; Factor RE; Kushi LH; Bernard PS | Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes | Cancer Epidemiol Biomarkers Prev | May | 2014 | 23:725–34 | PMC4105204 |
| Greenlee H; Kwan ML; Ergas IJ; Strizich G; Roh JM; Wilson AT; Lee M; Sherman KJ; Ambrosone CB; Hershman DL; Neugut AI; Kushi LH | Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study | BMC Cancer | May | 2014 | 14:382 | PMC4059470 |
| Kroenke CH; Sweeney C; Kwan ML; Quesenberry CP; Weltzien EK; Habel LA; Castillo A; Bernard PS; Factor RE; Kushi LH; Caan BJ | Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression | Breast Cancer Res Treat | Apr | 2014 | 144:689–99 | PMC4035036 |
| Kwan ML; Lo JC; Tang L; Laurent CA; Roh JM; Chandra M; Hahn TE; Hong CC; Sucheston-Campbell L; Hershman DL; Quesenberry CP, Jr.; Ambrosone CB; Kushi LH; Yao S | Bone health history in breast cancer patients on aromatase inhibitors | PLoS One | 2014 | 9:e111477 | PMC4213031 | |
| Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Hershman DL | Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer | Breast Cancer | Nov | 2014 | 21:780–5 | PMC4213210 |
| Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP, Jr.; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ | Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics | Cancer Epidemiol Biomarkers Prev | May | 2014 | 23:714–24 | PMC4011983 |
| Gomez SL; Shariff-Marco S; Von Behren J; Kwan ML; Kroenke CH; Keegan TH; Reynolds P; Kushi LH | Representativeness of breast cancer cases in an integrated health care delivery system | BMC Cancer | Oct | 2015 | 15:688 | PMC4604822 |
| Kwan ML; Bernard PS; Kroenke CH; Factor RE; Habel LA; Weltzien EK; Castillo A; Gunderson EP; Maxfield KS; Stijleman IJ; Langholz BM; Quesenberry CP, Jr.; Kushi LH; Sweeney C; Caan BJ | Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival | J Natl Cancer Inst | Jul | 2015 | 107 | PMC4554253 |
| Mandelblatt JS; Huang K; Makgoeng SB; Luta G; Song JX; Tallarico M; Roh JM; Munneke JR; Houlston CA; McGuckin ME; Cai L; Clarke Hillyer G; Hershman DL; Neugut AI; Isaacs C; Kushi L | Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data | J Oncol Pract | Jan | 2015 | 11:e1–8 | PMC4295421 |
| Zhu Q; Hu Q; Shepherd L; Wang J; Wei L; Morrison CD; Conroy JM; Glenn ST; Davis W; Kwan ML; Ergas IJ; Roh JM; Kushi LH; Ambrosone CB; Liu S; Yao S | The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology | Cancer Epidemiol Biomarkers Prev | Aug | 2015 | 24:1207–13 | PMC4526319 |
| Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL | Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study | JAMA Oncol | Sep | 2016 | 2:1170–6 | PMC5484521 |
| Hershman DL; Kushi LH; Hillyer GC; Coromilas E; Buono D; Lamerato L; Bovbjerg DH; Mandelblatt JS; Tsai WY; Zhong X; Jacobson JS; Wright JD; Neugut AI | Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) | Breast Cancer Res Treat | May | 2016 | 157:133–43 | PMC4867255 |
| Jones LW; Habel LA; Weltzien E; Castillo A; Gupta D; Kroenke CH; Kwan ML; Quesenberry CP, Jr.; Scott J; Sternfeld B; Yu A; Kushi LH; Caan BJ | Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer | J Clin Oncol | Aug | 2016 | 34:2743–9 | PMC5019746 |
| Jones LW; Kwan ML; Weltzien E; Chandarlapaty S; Sternfeld B; Sweeney C; Bernard PS; Castillo A; Habel LA; Kroenke CH; Langholz BM; Queensberry CP, Jr.; Dang C; Weigelt B; Kushi LH; Caan BJ | Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies | Cancer Res | Sep | 2016 | 76:5415–22 | PMC5026589 |
| Kwan ML; Yao S; Lee VS; Roh JM; Zhu Q; Ergas IJ; Liu Q; Zhang Y; Kutner SE; Quesenberry CP, Jr.; Ambrosone CB; Kushi LH | Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study | Breast Cancer Res Treat | Aug | 2016 | 159:119–29 | PMC5010992 |
| Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL | A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL) | Breast Cancer Res Treat | Jul | 2016 | 158:127–138 | PMC5492513 |
| Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ | Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer | Cancer | Jul | 2017 | 123:2535–2542 | PMC5474169 |
| Cespedes Feliciano EM; Kwan ML; Kushi LH; Weltzien EK; Castillo AL; Caan BJ | Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors | Breast Cancer Res Treat | Apr | 2017 | 162:549–557 | PMC5337404 |
| Engmann NJ; Ergas IJ; Yao S; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Fejerman L | Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study | Cancer Epidemiol Biomarkers Prev | Sep | 2017 | 26:1466–1469 | PMC5657515 |
| Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH | BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study | J Natl Cancer Inst | Feb | 2017 | 109 | PMC6093415 |
| Kwan ML; Roh JM; Laurent CA; Lee J; Tang L; Hershman D; Kushi LH; Yao S | Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer | Cancer Causes Control | Jun | 2017 | 28:557–562 | PMC5439523 |
| Shariff-Marco S; Von Behren J; Reynolds P; Keegan TH; Hertz A; Kwan ML; Roh JM; Thomsen C; Kroenke CH; Ambrosone C; Kushi LH; Gomez SL | Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study | Cancer Epidemiol Biomarkers Prev | Apr | 2017 | 26:505–515 | PMC5380478 |
| Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP, Jr.; Lee MM; Ambrosone CB; Kushi LH | Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study | JAMA Oncol | Mar | 2017 | 3:351–357 | PMC5473032 |
| Yao S; Zhang Y; Tang L; Roh JM; Laurent CA; Hong CC; Hahn T; Lo JC; Ambrosone CB; Kushi LH; Kwan ML | Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis | Breast Cancer Res Treat | Feb | 2017 | 161:501–513 | PMC5243170 |
| Check DK; Chawla N; Kwan ML; Pinheiro L; Roh JM; Ergas IJ; Stewart AL; Kolevska T; Ambrosone C; Kushi LH | Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions | Breast Cancer Res Treat | Aug | 2018 | 170:593–603 | PMC6528788 |
| Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH | Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system | Breast Cancer Res Treat | Aug | 2018 | 170:623–631 | PMC6026067 |
| Kwan ML; Yao S; Laurent CA; Roh JM; Quesenberry CP, Jr.; Kushi LH; Lo JC | Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy | Breast Cancer Res Treat | Apr | 2018 | 168:523–530 | PMC6534130 |
| Ritzwoller DP; Hassett MJ; Uno H; Cronin AM; Carroll NM; Hornbrook MC; Kushi LC | Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm | J Natl Cancer Inst | Mar | 2018 | 110:273–281 | PMC5972574 |
| Check DK; Kwan ML; Chawla N; Dusetzina SB; Valice E; Ergas IJ; Roh JM; Kolevska T; Rosenstein DL; Kushi LH | Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System | J Pain Symptom Manage | Mar | 2019 | 57:587–595 | PMC6386165 |
| Larsen V; Barlow WE; Yang JJ; Zhu Q; Liu S; Kwan ML; Ergas IJ; Roh JM; Hutchins LF; Kadlubar SA; Albain KS; Rae JM; Yeh IT; Ravdin PM; Martino S; Lyss AP; Osborne CK; Hortobagyi GN; Kushi LH; Hayes DF; Ambrosone CB; Yao S | Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study | Clin Breast Cancer | Aug | 2019 | 19:225–235 e2 | PMC6667288 |
| Liu Q; Yao S; Zhao H; Hu Q; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Liu S; Zhu Q | Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations | Cancer Med | Apr | 2019 | 8:1845–1853 | PMC6488149 |
| Shi Z; Rundle A; Genkinger JM; Cheung YK; Ergas IJ; Roh JM; Kushi LH; Kwan ML; Greenlee H | Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study | Breast Cancer Res Treat | Jan | 2020 | 179:229–240 | PMC7199498 |
| Shi Z; Rundle A; Genkinger JM; Cheung YK; Ergas IJ; Roh JM; Kushi LH; Kwan ML; Greenlee H | Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study | J Cancer Surviv | Jun | 2020 | 14:393–403 | PMC7955660 |
| Yao S; Laurent CA; Roh JM; Lo J; Tang L; Hahn T; Ambrosone CB; Kushi LH; Kwan ML | Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study | Breast Cancer Res Treat | Feb | 2020 | 180:187–195 | PMC7171589 |
| Anyene IC; Ergas IJ; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Cespedes Feliciano EM | Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study | Nutrients | Sep | 2021 | 13 | PMC8540603 |
| Aoki RF; Uong SP; Gomez SL; Alexeeff SE; Caan BJ; Kushi LH; Torres JM; Guan A; Canchola AJ; Morey BN; Lin K; Kroenke CH | Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California | Cancer | Dec | 2021 | 127:4602–4612 | PMC8997171 |
| Ergas IJ; Cespedes Feliciano EM; Bradshaw PT; Roh JM; Kwan ML; Cadenhead J; Santiago-Torres M; Troeschel AN; Laraia B; Madsen K; Kushi LH | Diet Quality and Breast Cancer Recurrence and Survival: The Pathways Study | JNCI Cancer Spectr | Apr | 2021 | 5 | PMC8062847 |
| Kroenke CH; Alexeeff S; Kushi LH; Kwan ML; Matthews KA | Clustering of Social and Physical Pain Variables and Their Association With Mortality in Two Population-Based Cohorts | Psychosom Med | Apr | 2021 | 83:228–238 | PMC8023720 |
| Lo JC; Laurent CA; Roh JM; Lee J; Chandra M; Yao S; Kwan ML | Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy | JAMA Netw Open | Nov | 2021 | 4:e2133861 | PMC8600383 |
| Wright JD; Kroenke CH; Kwan ML; Kushi LH | I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support" | Qual Health Res | May | 2021 | 31:1056–1068 | PMC8376224 |
| Greenlee H; Iribarren C; Rana JS; Cheng R; Nguyen-Huynh M; Rillamas-Sun E; Shi Z; Laurent CA; Lee VS; Roh JM; Santiago-Torres M; Shen H; Hershman DL; Kushi LH; Neugebauer R; Kwan ML | Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study | J Clin Oncol | May | 2022 | 40:1647–1658 | PMC9113215 |
| Kwan ML; Cheng RK; Iribarren C; Neugebauer R; Rana JS; Nguyen-Huynh M; Shi Z; Laurent CA; Lee VS; Roh JM; Shen H; Rillamas-Sun E; Santiago-Torres M; Hershman DL; Kushi LH; Greenlee H | Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study | J Clin Oncol | May | 2022 | 40:1635–1646 | PMC9113213 |
| Kwan ML; Cheng RK; Iribarren C; Shen H; Laurent CA; Roh JM; Hershman DL; Kushi LH; Greenlee H; Rana JS | Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer | Breast Cancer Res Treat | Jun | 2022 | 193:669–675 | PMC10461432 |
| Ondracek RP; Chen J; Marosy B; Szewczyk S; Medico L; Mohan AS; Nair P; Pratt R; Roh JM; Khoury T; Carpten J; Kushi LH; Palmer JR; Doheny K; Davis W; Higgins MJ; Yao S; Ambrosone CB | Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study | BMC Genomics | Aug | 2022 | 23:614 | PMC9404650 |
| Zhu Q; Schultz E; Long J; Roh JM; Valice E; Laurent CA; Radimer KH; Yan L; Ergas IJ; Davis W; Ranatunga D; Gandhi S; Kwan ML; Bao PP; Zheng W; Shu XO; Ambrosone C; Yao S; Kushi LH | UACA locus is associated with breast cancer chemoresistance and survival | NPJ Breast Cancer | Mar | 2022 | 8:39 | PMC8943134 |
| Conroy SM; Von Behren J; Kwan ML; Kushi LH; Kim MO; Iribarren C; Roh JM; Laurent CA; Thomsen C; Chu JN; Greenlee H; Gomez SL; Shariff-Marco S | Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study | Cancer | Aug | 2023 | 129:2395–2408 | PMC10506517 |
| Ergas IJ; Bradshaw PT; Cespedes Feliciano EM; Roh JM; Kwan ML; Laraia B; Madsen KA; Yao S; Thomsen C; Kushi LH | Hypothetical Interventions on Diet Quality and Lifestyle Factors to Improve Breast Cancer Survival: The Pathways Study | Cancer Epidemiol Biomarkers Prev | Dec | 2023 | 32:1716–1725 | PMC10841733 |
| Fiorica PN; Sheng H; Zhu Q; Roh JM; Laurent CA; Ergas IJ; Delmerico J; Kwan ML; Kushi LH; Ambrosone CB; Yao S | A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study | Cancer Res Commun | Jun | 2023 | 3:1104–1112 | PMC10286812 |
| Kwan ML; Lo JC; Laurent CA; Roh JM; Tang L; Ambrosone CB; Kushi LH; Quesenberry CP, Jr.; Yao S | A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting | J Cancer Surviv | Feb | 2023 | 17:139–149 | PMC8349930 |
| Kwan ML; Valice E; Ergas IJ; Roh JM; Caan BJ; Cespedes Feliciano EM; Kolevska T; Hartman TJ; Quesenberry CP, Jr.; Ambrosone CB; Kushi LH | Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study | Cancer | Dec | 2023 | 129:3938–3951 | PMC10840903 |
| Rillamas-Sun E; Kwan ML; Iribarren C; Cheng R; Neugebauer R; Rana JS; Nguyen-Huynh M; Shi Z; Laurent CA; Lee VS; Roh JM; Huang Y; Shen H; Hershman DL; Kushi LH; Greenlee H | Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer | Breast Cancer Res Treat | Aug | 2023 | 201:117–126 | PMC10498727 |
| Shariff-Marco S; Sangaramoorthy M; Ellis L; Thomsen C; Roh JM; Kroenke C; Valice E; Kwan ML; Ambrosone C; Kushi L; Gomez SL | Impact of Racial/Ethnic Discrimination on Quality of Life Among Breast Cancer Survivors | Am J Epidemiol | Feb | 2023 | 192:367–376 | PMC10372860 |
| Shieh Y; Roger J; Yau C; Wolf DM; Hirst GL; Swigart LB; Huntsman S; Hu D; Nierenberg JL; Middha P; Heise RS; Shi Y; Kachuri L; Zhu Q; Yao S; Ambrosone CB; Kwan ML; Caan BJ; Witte JS; Kushi LH; t Veer LV; Esserman LJ; Ziv E | Development and testing of a polygenic risk score for breast cancer aggressiveness | NPJ Precis Oncol | May | 2023 | 7:42 | PMC10185660 |
| Troeschel AN; Hartman TJ; McCullough LE; Ergas IJ; Collin LJ; Kwan ML; Ambrosone CB; Flanders WD; Bradshaw PT; Cespedes Feliciano EM; Roh JM; Wang Y; Valice E; Kushi LH | Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer | Cancer Epidemiol Biomarkers Prev | Jul | 2023 | 32:963–975 | PMC10330263 |
| Chua AV, Jr.; Sheng H; Liang E; Gandhi S; Kwan ML; Ergas IJ; Roh JM; Laurent CA; Yan L; Khoury T; Ambrosone CB; Kushi LH; Yao S | Epidemiology of early vs late recurrence among women with early stage estrogen receptor-positive breast cancer in the Pathways Study | J Natl Cancer Inst | Oct | 2024 | 116:1621–1631 | PMC11461155 |
| Ergas IJ; Cheng RK; Roh JM; Kushi LH; Kresovich JK; Iribarren C; Nguyen-Huynh M; Rana JS; Rillamas-Sun E; Laurent CA; Lee VS; Quesenberry CP; Greenlee H; Kwan ML | Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study | JNCI Cancer Spectr | Feb | 2024 | 8 | PMC11021810 |
| Hook C; Chatterjee U; Sheng H; Zhu Q; Robinson T; Roh JM; Laurent CA; Lee C; Delmerico J; Lo JC; Ambrosone CB; Kushi LH; Kwan ML; Yao S | A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors | NPJ Breast Cancer | Jan | 2024 | 10:9 | PMC10799916 |
| Khoury T; Mendicino L; Payne Ondracek R; Yao S; Davis W; Omilian AR; Kwan ML; Roh JM; D'Addario L; Valice E; Fernandez D; Ergas IJ; Chua AV, Jr.; Ambrosone CB; Kushi LH | Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer | JAMA Netw Open | Mar | 2024 | 7:e243345 | PMC10960203 |
| Kwan ML; Pimentel N; Izano M; Iribarren C; Rana JS; Nguyen-Huynh M; Cheng R; Laurent CA; Lee VS; Roh JM; Rillamas-Sun E; Hershman DL; Kushi LH; Greenlee H; Neugebauer R | Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study | PLoS One | 2024 | 19:e0310531 | PMC11412667 | |
| Langley BO; Rillamas-Sun E; Huang Y; Indorf A; Robles M; Feaster R; D'Addario L; Ergas IJ; Roh JM; Kushi LH; Greenlee H | Validation and Utility of Drug-Nutrient Interaction and Dietary Supplement Mechanistic Activity in the Natural Medicines Database | JCO Oncol Adv | 2024 | 1:e2400062 | PMC11698021 | |
| Leedy DJ; Voit JM; Rillamas-Sun E; Kwan ML; Shen H; Li S; Laurent CA; Rana JS; Lee VS; Roh JM; Huang Y; Greenlee H; Cheng RK | Blood Pressure and Cardiovascular Risk in Women With Breast Cancer: The Pathways Heart Study | JACC Adv | Sep | 2024 | 3:101207 | PMC11375265 |
| Sangaramoorthy M; Samayoa C; Inamdar PP; Roh JM; Valice E; Hong CC; Kwan ML; Ambrosone CB; Kushi LH; Gomez SL; Shariff-Marco S | Association between neighborhood stressors and allostatic load in breast cancer survivors: the Pathways Study | Am J Epidemiol | May | 2025 | 194:1264–1274 | PMC12055468 |
| Huang Y; Kwan ML; Heckbert SR; Smith NL; Othus M; Laurent CA; Roh JM; Rillamas-Sun E; Lee VS; Kolevska T; Cheng RK; Irribarren C; Nguyen-Huynh M; Hershman DL; Kushi LH; Greenlee H | Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors | JNCI Cancer Spectr | Jan | 2025 | 9 | PMC11879121 |
| Kresovich JK; Richards AR; Ergas IJ; Cannioto R; Thomsen C; Laurent CA; Shariff-Marco S; Rillamas-Sun E; Kolevska T; Yao S; Ambrosone C; Kushi L; Greenlee H; Kwan ML | Physical activity and incident cardiovascular disease in breast cancer survivors: the Pathways Study | JNCI Cancer Spectr | Jan | 2025 | 9 | PMC11737308 |
| Zimbalist A; Radimer KH; Ergas IJ; Roh JM; Quesenberry CP; Kwan ML; Kushi LH | Utilization of locally estimated scatterplot smoothing (LOESS) regression to estimate missing weights in a longitudinal cohort of breast cancer patients | Ann Epidemiol | Apr | 2025 | 104:55–60 | PMC11972875 |
| Ambrosone CB; Yao S; Long MD; Liu C; Chen J; Davis W; Zirpoli G; Payne-Ondracek R; Khoury T; Gong Z; Hu Q; Szewczyk S; Omilian AR; Bandera EV; Liu S; Kushi L; Higgins MJ; Palmer JR | Associations of DNA methylation in breast tumour subtypes with parity and breastfeeding in a cohort of 1459 Black women: implications for public health | BMJ Oncol | 2025 | 4:e000675 | PMC12164313 | |
| Bitsie KR; Pearson TA; Kwan ML; Yaghjyan L; Scarton L; Shariff-Marco S; Kushi LH; Cheng TD | Race and ethnicity and self-reported racial/ethnic discrimination in breast cancer patient interactions with providers in the Pathways Study | Breast Cancer Res Treat | Jan | 2025 | 209:355–366 | PMC11785627 |
| Ergas IJ; Cheng RK; Roh JM; Kresovich JK; Iribarren C; Nguyen-Huynh M; Rana JS; Rillamas-Sun E; Laurent CA; Lee VS; Quesenberry CP; Bhatt A; Yao S; Kushi LH; Greenlee H; Kwan ML | Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study | Breast Cancer Res Treat | May | 2025 | 211:139–150 | PMC11952977 |
| Cheng E; Hong CC; Ergas IJ; Caan BJ; Kwan ML; Roh JM; Cheng TD; Sharma NJ; Hanson JR; Minderman H; Sheng H; Yao S; Iyengar NM; Ambrosone CB; Kushi LH; Cespedes Feliciano EM | Plant-based diet, inflammation biomarkers and body composition among women with breast cancer: the Pathways Study | Br J Nutr | May | 2025 | 133:1309–1319 | PMC12284747 |
| Tang L; Wang Z; Hsiao HH; Kwan ML; Ergas IJ; Roh JM; Valice E; Yao S; Zhu Q; Quesenberry CP; Ambrosone CB; Kushi LH | Associations of Cruciferous Vegetable Intake with Breast Cancer Survival in a Diverse Population in the Pathways Study | Cancer Epidemiol Biomarkers Prev | Jul | 2025 | 34:1177–1187 | PMC12213201 |
| Kroenke CH; Kwan ML; Gomez SL; Shim V; Ergas IJ; Roh J; Kushi LH | Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System | Psychooncology | Nov | 2024 | 33:e70025 | PMC11817851 |